Jan 7, 2008 by Brian Orelli, PhDIlumina Tests New WatersIlumina reorganizes to concentrate on diagnostic tests.
Jan 4, 2008 by Brian Orelli, PhDMonsanto Rounds Up GrowthCorn prices spur growth, but the long-term growth is pegged to new seed traits.
Jan 4, 2008 by Brian Orelli, PhDWhat's That Test Going to Run Me?Get the real scoop on your medical bills before you leave your doctor's office.
Jan 4, 2008 by Brian Orelli, PhDRabid Growth at CrucellCrucell signs a marketing agreement with Sanofi, but who benefits more?
Jan 3, 2008 by Brian Orelli, PhDA Super Superbug Testing MarketBecton, Dickinson gets FDA approval of its latest (rapid) superbug detection test.
Jan 3, 2008 by Brian Orelli, PhD8 Generic-Drug Makers for 2008Big and small, these eight might not fall.
Jan 2, 2008 by Brian Orelli, PhDCongestion in the OTC MarketJ&J already has generic competition for its new drug.
Dec 31, 2007 by Brian Orelli, PhDBest Stock for 2008: Johnson & JohnsonDown on its luck for 2007, it'll rebound in 2008.
Dec 31, 2007 by Brian Orelli, PhDBoston Scientific Restarts Its HeartBoston Scientific receives European approval for its defibrillator.
Dec 28, 2007 by Brian Orelli, PhDThe Biggest Health-Care IPOs of 2007Some were flops. Here are the best.
Dec 27, 2007 by Brian Orelli, PhDDrugmaker Growth: The China ConnectionDrugmakers get part of the job done outside of the U.S.
Dec 26, 2007 by Brian Orelli, PhDTeva's Heartburning BattleLooks like the drugmaker will be spending even more time in court.
Dec 26, 2007 by Brian Orelli, PhDInflamed Anti-Inflammatory Contract RevisedJ&J and Schering revise their agreement over anti-TNF compounds.
Dec 24, 2007 by Brian Orelli, PhDCatching Up With Par PharmaceuticalThe maker of generics releases its third-quarter results with a little time to spare.
Dec 24, 2007 by Brian Orelli, PhDGenentech Bails on AltusAltus Pharmaceuticals still testing drug after Genentech leaves development partnership.
Dec 20, 2007 by Brian Orelli, PhDWhat Was That Clinical Trial For?EPIX initiates a safety trial and gets good efficacy data.
Dec 20, 2007 by Brian Orelli, PhD2007: The Year Pharma Fell in Love With BiologicsTraditional drug companies want what biotech companies have. Will the infatuation last?
Dec 19, 2007 by Brian Orelli, PhDNew Beta Blocker on the Crowded StreetForest and Mylan receive FDA approval for Bystolic.
